6N1K

Full-length human phenylalanine hydroxylase (PAH) in the resting state

6N1K の概要

• エントリーDOI: 10.2210/pdb6n1k/pdb
• 分子名称: Phenylalanine-4-hydroxylase, CHLORIDE ION, FE (III) ION, ... (4 entities in total)
• 機能のキーワード: resting-state pah, allosterically controlled aromatic amino acid hydroxylase, oxidoreductase
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 4
• 化学式量合計: 207491.78

構造登録者

Arturo, E.C.,Jaffe, E.K. (登録日: 2018-11-08, 公開日: 2019-05-22, 最終更新日: 2023-10-11)

主引用文献

Arturo, E.C.,Gupta, K.,Hansen, M.R.,Borne, E.,Jaffe, E.K.
Biophysical characterization of full-length human phenylalanine hydroxylase provides a deeper understanding of its quaternary structure equilibrium.
J.Biol.Chem., 294:10131-10145, 2019

PubMed Abstract: Dysfunction of human phenylalanine hydroxylase (hPAH, EC 1.14.16.1) is the primary cause of phenylketonuria, the most common inborn error of amino acid metabolism. The dynamic domain rearrangements of this multimeric protein have thwarted structural study of the full-length form for decades, until now. In this study, a tractable C29S variant of hPAH (C29S) yielded a 3.06 Å resolution crystal structure of the tetrameric resting-state conformation. We used size-exclusion chromatography in line with small-angle X-ray scattering (SEC-SAXS) to analyze the full-length hPAH solution structure both in the presence and absence of Phe, which serves as both substrate and allosteric activators. Allosteric Phe binding favors accumulation of an activated PAH tetramer conformation, which is biophysically distinct in solution. Protein characterization with enzyme kinetics and intrinsic fluorescence revealed that the C29S variant and hPAH are otherwise equivalent in their response to Phe, further supported by their behavior on various chromatography resins and by analytical ultracentrifugation. Modeling of resting-state and activated forms of C29S against SAXS data with available structural data created and evaluated several new models for the transition between the architecturally distinct conformations of PAH and highlighted unique intra- and inter-subunit interactions. Three best-fitting alternative models all placed the allosteric Phe-binding module 8-10 Å farther from the tetramer center than do all previous models. The structural insights into allosteric activation of hPAH reported here may help inform ongoing efforts to treat phenylketonuria with novel therapeutic approaches.

PubMed: 31076506
DOI: 10.1074/jbc.RA119.008294

実験手法

X-RAY DIFFRACTION (3.057 Å)